Profile image
Story Views

Last Hour:
Last 24 Hours:

Worldwide Analgesics Market 2016 Trend, Analysis and Overview

Wednesday, November 16, 2016 3:51
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain.

Publisher’s analysts forecast the global analgesics market to grow at a CAGR of 4.28% during the period 2016-2020.

For more information about this report:

Covered in this report 
The report covers the present scenario and the growth prospects of the global analgesics market for 2016-2020. To calculate the market size, Publisher considers the revenue generated from the total consumption of analgesics globally. The report does not include revenue generated from the aftermarket service of the product.

The market is divided into the following segments based on geography: 
- Americas

Publisher’s report, Global Analgesics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
- Pfizer
- Bayer HealthCare
- Sanofi
- Endo
- Johnson & Johnson
- Purdue Pharma


Request Sample Copy at   


Other prominent vendors 
- Achelios Therapeutics
- Alder BioPharmaceuticals
- Allergan
- Amgen
- AstraZeneca 
- Baxter
- Boehringer Ingelheim 
- Bristol Myers Squibb 
- CoLucid Pharmaceuticals
- Daiichi Sankyo 
- Dr. Reddy’s Laboratories
- El Lilly & Company
- F. Hoffmann La Roche 
- GlaxoSmithKline 
- GW Pharmaceuticals
- Hospira
- Immune Pharmaceuticals
- Innovative Med Concepts 
- Merck
- NeurAxon
- Novartis 
- OptiNose
- Pain Therapeutics
- RedHill
- Sorrento Therapeutics
- Suda
- Taro Pharmaceuticals Industries
- Teva Pharmaceuticals Industries
- Tonix Pharmaceuticals 
- Trigemina 
- UCB 
- Valeant Pharmaceuticals International
- WEX Pharmaceuticals
- Zynerba Pharmaceuticals 

Market driver 
- Increase in self-medication
- For a full, detailed list, view our report 

Market challenge 
- Preference for alternative therapies
- For a full, detailed list, view our report 

Market trend 
- Accelerated use of online resources
- For a full, detailed list, view our report 

Inquire for Report at   

Contact Us:

Call: +1-646-491-9876

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.